Christina M. Henderson

发表

Multicenter Study Demonstrates Standardization Requirements for Mold Identification by MALDI-TOF MS

Gongyi Shi, Markus Kostrzewa, Meghan A. Wallace, 2019, Front. Microbiol..

Rapid one-step protein extraction method for the identification of mycobacteria using MALDI-TOF MS.

Christina M. Henderson, Jamie K. Lemon, A. Zelazny, 2019, Diagnostic microbiology and infectious disease.

Performance of RGM Medium for Isolation of Nontuberculous Mycobacteria from Respiratory Specimens from Non-Cystic Fibrosis Patients

Christina M. Henderson, A. Zelazny, J. Perry, 2018, Journal of Clinical Microbiology.

A High-Throughput Screening Assay for Fungicidal Compounds against Cryptococcus neoformans

Christina M. Henderson, Wei Zheng, S. Metallo, 2014, Journal of biomolecular screening.

Multicenter Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Study for Identification of Clinically Relevant Nocardia spp

Christina M. Henderson, K. Frank, A. Zelazny, 2016, Journal of Clinical Microbiology.

Aspergillus tanneri sp. nov., a New Pathogen That Causes Invasive Disease Refractory to Antifungal Therapy

Christina M. Henderson, S. Holland, L. Folio, 2012, Journal of Clinical Microbiology.

VT-1598 inhibits the in vitro growth of mucosal Candida strains and protects against fluconazole-susceptible and -resistant oral candidiasis in IL-17 signalling-deficient mice

Christina M. Henderson, E. Garvey, C. M. Yates, 2018, The Journal of antimicrobial chemotherapy.

Development of a Clinically Comprehensive Database and a Simple Procedure for Identification of Molds from Solid Media by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry

Christina M. Henderson, A. Zelazny, S. K. Drake, 2012, Journal of Clinical Microbiology.

Identification of Multiple Cryptococcal Fungicidal Drug Targets by Combined Gene Dosing and Drug Affinity Responsive Target Stability Screening

Christina M. Henderson, A. Wang, Wei Zheng, 2016, mBio.

VT-1129 and VT-1161 have in vitro activity against Candida isolates from patients with chronic mucocutaneous candidiasis

Christina M. Henderson, E. Garvey, A. Zelazny, 2016 .

Abstract LB007: CFT7455: A novel, IKZF1/3 degrader that demonstrates potent tumor regression in IMiD-resistant multiple myeloma (MM) xenograft models

Christina M. Henderson, A. Good, D. Proia, 2021, Experimental and Molecular Therapeutics.

VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans

Christina M. Henderson, E. Garvey, A. Zelazny, 2018, The Journal of antimicrobial chemotherapy.

Aspergillus tanneri sp. nov., a New Pathogen That Causes Invasive Disease Refractory to Antifungal Therapy

Christina M. Henderson, S. Holland, L. Folio, 2012, Journal of Clinical Microbiology.